ReShape Lifesciences, Inc. (RSLS): Kapitalisasi marang pendapatan
ReShape Lifesciences (RSLS) develops minimally invasive systems to combat obesity, focusing on the bariatric segment. The median P/S confirms this trend, with the current parameter equal to 1.60. Business growth is constrained by the approval speed of new models and insurance limits. Margins are currently declining due to the expansion of modern weight-loss drugs, which creates significant risks for asset valuation.
Rincian analitis perusahaan ReShape Lifesciences (RSLS)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal ReShape Lifesciences|RSLS - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas reshapelifesciences.com|RSLS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ReShape Lifesciences Inc|RSLS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ReShape Lifesciences|Rasio jangkoan perantara reshapelifesciences.com
- data bathi lan kelipatan valuasi:
RSLS - Bathi resik|Bathi resik sing dikarepake ReShape Lifesciences|RSLS - Rasio rega marang bathi|Pangali forward rega marang bathi reshapelifesciences.com|RSLS - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA ReShape Lifesciences Inc|RSLS - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan ReShape Lifesciences|RSLS - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan reshapelifesciences.com|RSLS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ReShape Lifesciences
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:RSLS ReShape Lifesciences, Inc.
The P/S multiple reflects the market value of ReShape Lifesciences (RSLS) relative to its annual sales volume, allowing investors to assess the premium paid per unit of revenue. By analyzing the current P/S valuation, the market weighs business growth rates against the costs of environmental upgrades to production lines and the implementation of recyclable packaging to determine the company's fundamental stability within the medical equipment sector.
Pesaing ReShape Lifesciences
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|beyondair.net (XAIR) - Rasio rega marang pendapatan|profusa.com - Rasio kapitalisasi pasar marang pendapatan|SSKN (STRATA Skin Sciences Inc.) - Multiplikator P/S|Rega marang dodolan glucotrack.com GCTK|Rasio rega marang pendapatan NanoVibronix (NAOV)|Koefisien rega marang pendapatan Venus Concept Corporation|Multiplikator P/S NUWE (Nuwellis, Inc.)|Rasio kapitalisasi pasar marang pendapatan AEMD|TransEnterix - Multiplikator P/S|AVGR - Multiplikator P/S|BioSig Technologies, Inc (BSGM) - Rasio rega marang pendapatan|Rasio rega marang dodolan CUTR (Cutera Inc)|KNW (Know Labs, Inc.) - Multiplikator P/S|Rega marang dodolan inarimedical.com NARI|Kapitalisasi marang pendapatan NVRO (Nevro)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
